New Treatments for Deadly Idiopathic Pulmonary Fibrosis

Two recently approved drugs, Esbriet and Ofev, slow the progression of idiopathic pulmonary fibrosis and help lungs function longer, as more patients are diagnosed with the disease.
Source: WSJ.com: The Informed Patient - Category: Consumer Health News Tags: FREE Source Type: blogs
More News: Health